• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体-1 抑制 Maspin 肿瘤抑制基因,决定黑色素瘤的转移表型。

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.

机构信息

Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):626-31. doi: 10.1073/pnas.1006886108. Epub 2010 Dec 27.

DOI:10.1073/pnas.1006886108
PMID:21187389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3021062/
Abstract

The thrombin receptor protease activated receptor-1 (PAR-1) is overexpressed in metastatic melanoma cell lines and tumor specimens. Previously, we demonstrated a significant reduction in tumor growth and experimental lung metastasis after PAR-1 silencing via systemic delivery of siRNA encapsulated into nanoliposomes. Gene expression profiling identified a 40-fold increase in expression of Maspin in PAR-1-silenced metastatic melanoma cell lines. Maspin promoter activity was significantly increased after PAR-1 silencing, suggesting that PAR1 negatively regulates Maspin at the transcriptional level. ChIP analyses revealed that PAR-1 decreases binding of Ets-1 and c-Jun transcription factors to the Maspin promoter, both known to activate Maspin transcription. PAR-1 silencing did not affect Ets-1 or c-Jun expression; rather it resulted in increased expression of the chromatin remodeling complex CBP/p300, as well as decreased activity of the CBP/p300 inhibitor p38, resulting in increased binding of Ets-1 and c-Jun to the Maspin promoter and higher Maspin expression. Functionally, Maspin expression reduced the invasive capability of melanoma cells after PAR-1 silencing, which was abrogated after rescuing with PAR-1. Furthermore, tumor growth and experimental lung metastasis was significantly decreased after expressing Maspin in a metastatic melanoma cell line. Moreover, silencing Maspin in PAR-1-silenced cells reverted the inhibition of tumor growth and experimental lung metastasis. Herein, we demonstrate a mechanism by which PAR-1 negatively regulates the expression of the Maspin tumor-suppressor gene in the acquisition of the metastatic melanoma phenotype, thus attributing an alternative function to PAR-1 other than coagulation.

摘要

凝血酶受体蛋白酶激活受体-1(PAR-1)在转移性黑色素瘤细胞系和肿瘤标本中过度表达。先前,我们通过全身递送包裹在纳米脂质体中的 siRNA 证明了 PAR-1 沉默后肿瘤生长和实验性肺转移显著减少。基因表达谱分析表明,PAR-1 沉默的转移性黑色素瘤细胞系中 Maspin 的表达增加了 40 倍。PAR-1 沉默后 Maspin 启动子活性显著增加,表明 PAR1 在转录水平上负调控 Maspin。ChIP 分析显示,PAR-1 减少了 Ets-1 和 c-Jun 转录因子与 Maspin 启动子的结合,这两种转录因子都已知能激活 Maspin 转录。PAR-1 沉默不影响 Ets-1 或 c-Jun 的表达;相反,它导致染色质重塑复合物 CBP/p300 的表达增加,以及 CBP/p300 抑制剂 p38 的活性降低,导致 Ets-1 和 c-Jun 与 Maspin 启动子的结合增加和更高的 Maspin 表达。功能上,PAR-1 沉默后 Maspin 表达降低了黑色素瘤细胞的侵袭能力,而在用 PAR-1 挽救后这种作用被消除。此外,在转移性黑色素瘤细胞系中表达 Maspin 后,肿瘤生长和实验性肺转移显著减少。此外,在 PAR-1 沉默细胞中沉默 Maspin 恢复了对肿瘤生长和实验性肺转移的抑制。在此,我们证明了 PAR-1 通过负调控 Maspin 肿瘤抑制基因的表达来获得转移性黑色素瘤表型的机制,从而为 PAR-1 赋予了除凝血以外的另一种功能。

相似文献

1
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.蛋白酶激活受体-1 抑制 Maspin 肿瘤抑制基因,决定黑色素瘤的转移表型。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):626-31. doi: 10.1073/pnas.1006886108. Epub 2010 Dec 27.
2
The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.凝血酶受体(PAR-1)在黑色素瘤转移中的新作用——一个可能的治疗靶点。
Oncotarget. 2011 Jan-Feb;2(1-2):8-17. doi: 10.18632/oncotarget.211.
3
Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.蛋白酶激活受体-1的过表达通过调节连接蛋白43促进黑色素瘤转移。
Cancer Res. 2009 Aug 15;69(16):6730-7. doi: 10.1158/0008-5472.CAN-09-0300.
4
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.蛋白酶激活受体1与血小板活化因子受体之间的相互作用调节黑色素瘤细胞粘附分子(MCAM/MUC18)的表达及黑色素瘤转移。
J Biol Chem. 2009 Oct 16;284(42):28845-55. doi: 10.1074/jbc.M109.042150. Epub 2009 Aug 24.
5
Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).人工转录因子(ATFs)激活非小细胞肺癌(NSCLC)细胞中的 MASPIN。
Epigenetics. 2011 Feb;6(2):224-35. doi: 10.4161/epi.6.2.13700. Epub 2011 Feb 1.
6
Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.Maspin表达由p63反式激活,对肺癌进展的调节至关重要。
Cancer Res. 2004 Oct 1;64(19):6900-5. doi: 10.1158/0008-5472.CAN-04-1657.
7
Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.通过Ets和Ap1转录位点的反式激活决定了肿瘤抑制基因maspin的表达。
Cell Growth Differ. 1997 Feb;8(2):179-86.
8
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.通过全身递送脂质体包裹的蛋白酶激活受体-1小干扰RNA靶向黑色素瘤生长和转移
Cancer Res. 2008 Nov 1;68(21):9078-86. doi: 10.1158/0008-5472.CAN-08-2397.
9
Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma.激活蛋白-2α的缺失导致蛋白酶激活受体-1的过表达,并与人黑色素瘤的恶性表型相关。
J Biol Chem. 2003 Nov 21;278(47):46632-42. doi: 10.1074/jbc.M309159200. Epub 2003 Sep 15.
10
Suppression of breast tumor growth and metastasis by an engineered transcription factor.工程化转录因子抑制乳腺肿瘤生长和转移。
PLoS One. 2011;6(9):e24595. doi: 10.1371/journal.pone.0024595. Epub 2011 Sep 13.

引用本文的文献

1
Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects.在恢复上皮内稳态过程中整合Maspin与p53的肿瘤抑制活性:一个工作假说及应用前景。
Front Oncol. 2022 Nov 29;12:1037794. doi: 10.3389/fonc.2022.1037794. eCollection 2022.
2
Protease-activated receptors in health and disease.蛋白酶激活受体在健康和疾病中的作用。
Physiol Rev. 2023 Jan 1;103(1):717-785. doi: 10.1152/physrev.00044.2021. Epub 2022 Jul 28.
3
Investigation of the Subcellular Localization-Dependent Anti- or Pro-Tumor Functions of Maspin in Human Lung Adenocarcinoma Cell Line.人肺腺癌细胞系中组织蛋白酶抑制剂maspin亚细胞定位依赖性抗肿瘤或促肿瘤功能的研究
Yonago Acta Med. 2022 Jan 4;65(1):44-52. doi: 10.33160/yam.2022.02.006. eCollection 2022 Feb.
4
Modulation of the Complement System by Neoplastic Disease of the Central Nervous System.中枢神经系统肿瘤性疾病对补体系统的调节。
Front Immunol. 2021 Oct 4;12:689435. doi: 10.3389/fimmu.2021.689435. eCollection 2021.
5
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead.嵌合抗原受体 (CAR) T 细胞疗法治疗转移性黑色素瘤:挑战与展望。
Cells. 2021 Jun 9;10(6):1450. doi: 10.3390/cells10061450.
6
Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.组织因子与癌症:调控、肿瘤生长和转移。
Semin Thromb Hemost. 2019 Jun;45(4):385-395. doi: 10.1055/s-0039-1687894. Epub 2019 May 16.
7
Transcriptional Landscape of PARs in Epithelial Malignancies.上皮性恶性肿瘤中 PARs 的转录景观。
Int J Mol Sci. 2018 Nov 2;19(11):3451. doi: 10.3390/ijms19113451.
8
Protease-activated receptor-1 impedes prostate and intestinal tumor progression in mice.蛋白酶激活受体-1 抑制小鼠前列腺和肠道肿瘤的进展。
J Thromb Haemost. 2018 Nov;16(11):2258-2269. doi: 10.1111/jth.14277. Epub 2018 Sep 27.
9
Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.蛋白酶激活受体 1 的激活增强多柔比星所致的心脏毒性。
J Mol Cell Cardiol. 2018 Sep;122:80-87. doi: 10.1016/j.yjmcc.2018.08.008. Epub 2018 Aug 10.
10
Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection.蛋白酶激活受体及其他G蛋白偶联受体:与黑色素瘤的关联
Front Genet. 2016 Jun 15;7:112. doi: 10.3389/fgene.2016.00112. eCollection 2016.

本文引用的文献

1
BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells.BRCA1 185delAG 突变蛋白 BRAt 上调卵巢上皮细胞中的 maspin。
Gynecol Oncol. 2010 Feb;116(2):262-8. doi: 10.1016/j.ygyno.2009.10.052. Epub 2009 Nov 10.
2
Novel targeted therapeutics for metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌的新型靶向治疗药物。
Cancer Lett. 2010 May 1;291(1):1-13. doi: 10.1016/j.canlet.2009.08.012. Epub 2009 Aug 29.
3
Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.蛋白酶激活受体-1的过表达通过调节连接蛋白43促进黑色素瘤转移。
Cancer Res. 2009 Aug 15;69(16):6730-7. doi: 10.1158/0008-5472.CAN-09-0300.
4
Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma.乳腺丝抑蛋白表达、血管生成、预后参数及恶性黑色素瘤的预后情况
J Am Acad Dermatol. 2009 May;60(5):758-66. doi: 10.1016/j.jaad.2009.01.018.
5
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.地诺单抗用于接受静脉双膦酸盐治疗后的前列腺癌、乳腺癌或其他肿瘤骨转移患者的随机II期试验。
J Clin Oncol. 2009 Apr 1;27(10):1564-71. doi: 10.1200/JCO.2008.19.2146. Epub 2009 Feb 23.
6
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.通过全身递送脂质体包裹的蛋白酶激活受体-1小干扰RNA靶向黑色素瘤生长和转移
Cancer Res. 2008 Nov 1;68(21):9078-86. doi: 10.1158/0008-5472.CAN-08-2397.
7
Protease-activated receptor signaling: new roles and regulatory mechanisms.蛋白酶激活受体信号传导:新作用与调控机制
Curr Opin Hematol. 2007 May;14(3):230-5. doi: 10.1097/MOH.0b013e3280dce568.
8
Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.核因子激活的IKKα通过抑制Maspin来控制前列腺癌转移。
Nature. 2007 Apr 5;446(7136):690-4. doi: 10.1038/nature05656. Epub 2007 Mar 18.
9
Loss of maspin expression contributes to a more invasive potential in malignant melanoma.乳腺丝抑蛋白表达缺失促使恶性黑色素瘤具有更强的侵袭潜能。
Pigment Cell Res. 2007 Apr;20(2):112-9. doi: 10.1111/j.1600-0749.2007.00363.x.
10
Biological functions of maspin.乳腺丝抑蛋白的生物学功能。
J Cell Physiol. 2006 Dec;209(3):617-24. doi: 10.1002/jcp.20782.